The University of Texas School of Public Health at Houston 1200 Pressler st, RAS E717 Houston, Texas 77030

Size: px
Start display at page:

Download "The University of Texas School of Public Health at Houston 1200 Pressler st, RAS E717 Houston, Texas 77030"

Transcription

1 CURRICULUM VITAE Lu-Yu Hwang, M.D. I. GENERAL BIOGRAPHICAL INFORMATION A. Personal Mailing Address: The University of Texas School of Public Health at Houston 1200 Pressler st, RAS E717 Houston, Texas Address: Telephone/Voice Mail: (713) B. Current Position(s) Professor, Department of Epidemiology, Human Genetics,,and Environment Science, The University of Texas, School of Public Health at Houston Th Director, Laboratory of Virology and STD Research, Center for Infectious Diseases, The University of Texas, School of Public Health at Houston December 8, 2014 Adjunct Professor, Department of Epidemiology, Division of Cancer Prevention, The University of Texas M.D. Anderson Cancer Center at Houston C. Education and Training 1. Undergraduate/Graduate Education National Taiwan University, Medical College, Taiwan, Republic of China, M.B.B.S. (M.D. equivalent), Postgraduate Training Resident, Pediatrics, National Taiwan University Hospital, Taiwan, Research Fellow, Epidemiology and Clinical Investigation, University of Washington Medical Research Unit (UWMRU), American University Medical Research Center, Taipei, Taiwan, Certifications and Licenses US Educational Commission for Foreign Medical Graduates (ECFMG), 1974 Diplomat Medicine of Republic of China (Physician License), 1976 The Pediatric Association of the Republic of China, (Board of Pediatrics), 1978 US Medical Board FLEX Examination, Component 1(1986), Component 2(1992) Infectious Disease Society of America, 1987 American College of Epidemiology, 1993 D. Academic Appointments

2 Professor (tenured,1996), Department of Epidemiology, Human Genetics,,and Environment Science The University of Texas, School of Public Health at Houston, 2007-present Director, Laboratory of Virology and STD Research (former Hepatitis/HIV Research), Center for Infectious Diseases, The University of Texas, School of Public Health at Houston, 1993-present Professor, Infectious Diseases and Virology/Gene Therapy Program, The University of Texas, Graduate School of Biomedical Science at Houston, Associate Professor (tenured,1996), Division of Epidemiology and Disease Control, The University of Texas, School of Public Health at Houston, Associate Professor, Infectious Diseases and Virology/Gene Therapy Program, The University of Texas, Graduate School of Biomedical Science at Houston, Adjunct Associate Professor, Department of Epidemiology, Division of Cancer Prevention, The University of Texas M.D. Anderson Cancer Center at Houston, Visiting Professor, Xi an Jiaotong University, and Nanjing University, China, Associate Professor, Associate Professor,(cross appointment), Department of Pediatrics, University of Texas Medical School at Houston, Assistant Professor, Human Genetic Center, The University of Texas, Graduate School of Biomedical Science at Houston, Assistant Professor, (cross appointment), Epidemiology Discipline, The University of Texas, School of Public Health at Houston, Assistant Professor, (cross appointment), Department of Pediatrics, The University of Texas Medical School at Houston, Adjunct Assistant Professor, Department of Epidemiology, The university of Texas M.D. Anderson Cancer at Houston Visiting Associate Professor, Department of Microbiology & Immunology, National Yang Ming Medical College, Taipei, Taiwan, Assistant Research Professor, Department of Pediatrics and Laboratory Medicine, The University of California at San Francisco, CA, Assistant Research Professor, Department of Epidemiology, The University of Washington, School of Public Health, Seattle, WA, Associate Director and Investigator, The American University Medical Research Center, Taipei, Taiwan, December 8,

3 E. Past Clinical Appointments Department of Pediatrics, The University of California at San Francisco, California, Department of Pediatrics, The- National Taiwan University Hospital, Taipei, Taiwan, F. Professional Societies USA American College of Epidemiology (ACE) American Public Health Association (APHA) Infectious Diseases Society of America (IDSA) North America Professor Taiwanese Association (NAPTA) Society for Epidemiologic Research (SER) Society for Chinese Bioscience Association (SCBA) Texas Medical Association & Harris County Medical Society International Asian Pacific Association for the Study of the Liver International AIDS Society Taiwan, Republic of China Chinese Society of Microbiology and Immunology Formosan Medical Association Gastroenterological Society of the Republic of China Pediatric Association of the Republic of China G. Honors and Awards Excellence in Research Incentive Award, UTSPH Excellence in Research Incentive Award, UTSPH Excellence in Research Incentive Award, UTSPH Excellence in Research Incentive Award, UTSPH - Dean s Teaching Excellence Award, UTSPH Excellence in Research Incentive Award, UTSPH - Excellent in Teaching Incentive Award; UTSPH Excellence in Research Incentive Award, UTSPH 2006-James H. Nakano Citation Award from the National Center for Infectious Diseases of the Centers for Disease Control and Prevention; Excellence in Research Incentive Award, UTSPH Excellence in Research Incentive Award, UTSPH 2004-Excellence in Research Incentive Award, UTSPH 2003-Excellence in Research Incentive Award, UTSPH December 8,

4 2002-Excellence in Research Incentive Award, UTSPH - Excellence in Scholarship (Teaching) Incentive Award; UTSPH Excellence in Research Incentive Award, UTSPH - Excellence in Scholarship Incentive Award; UTSPH Excellence in Scholarship (Teaching) Incentive Award, UTSPH Excellence in Research Incentive Award, Excellence in Scholarship (Teaching) Incentive Award; UTSPH 1999-Dean s Teaching Award, UT Graduate School of Biomedical Science 1998-Excellence in Research Incentive Award, UTSPH 1997-Excellence in Research Incentive Award, UTSPH; 1997-Dean s Teaching Award, UT Graduate School of Biomedical Science Excellence in Research Incentive Award, UTSPH 1995-Excellence in Research Incentive Award, UTSPH; 1995-Dean s Teaching Award, UT Graduate School of Biomedical Science 1993-Dean s Teaching Award, UT Graduate School of Biomedical Science 1990-Outstanding Leadership Award, Over the Hill Inc. Houston, Texas, 1978-Mead Johnson Pediatric Research Awards, 1978 II. RESEARCH INFORMATION A. Current, and Past and Research Support Active. Co-Investigator (5%), The feasibility of self/partner-assisted digital anal exams for cancer screening. NCI, R21 (1R21CA181901), project period of ((Principal Investigator: R. Alan G. Nyitray, PhD) Co-Investigator (5%),YMAP: Young Men s Affiliation Project of HIV Risk and Prevention Venues NIH/NIMH (1R01MH100021) project period of (Principal Investigator: Kayo Fujimoto, PhD Co- Investigator (2.5%), Genome Wide Associate Study of hepatocellular carcinoma, National Cancer Institute, 1R01CA A1, Project period of (Principal Investigator: Manal Hassan, MD PhD of MDACC.) Completed Training Grants: Mentor CPRIT FMS# Collaborative Training of A New Cadre of Innovative Cancer Prevention Researchers (PI: P Mullan and R. Ness, UTSPH). Budget: $2,617,614 (6/18/ /17/2013). NIH/Fogarty International Center 5D43TW S2 CITAR The UTSPH Program for Advanced Training on AIDS Research, Mentor (PI: Palmer December 8,

5 Beasley/Lu-Yu Hwang). Budget: $1,674,377 (6/1/2006-8/31/2013). Completed Research Grants Consultant (2%), Innovative strategies for breast cancer immunotherapy, funded by Department of Defense to MDACC for 9/30/ /29/2013. Principle Investigator: Feng Wang-Johanning, MD, PhD of MD Anderson Cancer Center, Department of immunology Principle investigator (10%), Technology-based Intervention to improve treatment adherence for people living with HIV infection in Vietnam. National Institute of Health/Fogarty International Center; (#1D43 TW007669) supplement. Total cost of $92,593 for period 6/1/2012-8/31/2013 Director and principal investigator (10%), Center for International Training on AIDS Research (CITAR)-The UTSPH Program for Advanced Training on AIDS Research, National Institute of Health/Fogarty International Center; (#1D43 TW007669), Total cost of $279,482 for project period:8/15/2011-8/31/2013. (Principal Investigator: R. Palmer Beasley, MD, 7/1/2006-5/31/2012 (Proj ID: ) Associate Director and Co-investigator (5%), Center for International Training on AIDS Research (CITAR)-The UTSPH Program for Advanced Training on AIDS Research, National Institute of Health/Fogarty International Center; (#1D43 TW007669), Total cost of $1,415,075 for project period:7/1/2006-6/30/2011. (Principal Investigator: R. Palmer Beasley, MD) Co-investigator and collaborator (5%), Determine Whether HIV Transient Infection Occurs, National Institutes of Allergy and Infectious Diseases,(NIAID#5R01A ). Total cost of 1,868,416 for project period: 12/1/ /30/2010. (Principal Investigator: Miles Cloyd, PhD of UTMB) Principal Investigator (5%) of the supplement subcontract from UTMB, Total cost of 150,000 for project period :8/1/2008-7/31/2011. Ruth L.Kirschstein National Research Service Award Postdoctoral Fellowship (F32). Close Relationships and HIV Risk among Inner-City Drug Users. National Institute of Drug Abuse, Project period: 1/1/08-12/31/10 (Principal Investigator Follow: :Eric A. Ratliff, PhD). Principal Investigator (25%), A Hepatitis B Vaccination Model for HIV vaccine trials in drug user, National Institute of Drug Abuse (NIDA# 1R01DA017505). Total cost of $3,397,721 for project period: 07/01/ /30/ Principal investigator (5%), Evaluating Potential Exposure to Blood and Risk of HCV in Persons without Traditional Risk Factors, Centers for Disease Control & Prevention (CDC #U50/CCU616922). Total cost of $300,000 for project period: 09/1/1999-8/31/ Principal Investigator (10%), Perinatal and Household Transmission of HCV, , Centers for Disease Control & Prevention (CDC #U50/CCU615187). Total cost of $604,670 project period: 09/01/1997-8/31/ Co-Principal Investigator (5%), Crack Cocaine Use as a Major Risk for HIV Transmission, Texas Department of Health (TCADA). Total cost of $ 73,000 for project period: 09/01/1996-8/31/1999. December 8,

6 Co-Principal Investigator (10%), Syphilis Prevention in Houston, Texas, Centers for Disease Control & Prevention (CDC #R30/CCR612016) Total cost of $ 1,583,690 for project period of 09/01/1995-8/31/2000. (Principal Investigator, Michael Ross, PhD).. Principal Investigator (5%), Prevalence of Markers for STDs in Homeless Youth, Houston Institute for Protective Youth, Total cost of $4,105.75, for project period: Principal Investigator (5%), Household Survey on Anti-HCV Positive Pregnant Women, Centers for Disease Control & Prevention (supplement of CDC # ). Total cost of $118,530 for project period: 09/01/1994-8/31/ Principal Investigator (12.5%), Multi-Center Study to Assess the Risk and Consequences of Hepatitis C Virus (HCV) Transmission from Mothers to Infants, , Centers for Disease Control & Prevention (CDC # ) Total cost of $ 939,642 for project period of 09/01/1993-8/31/ Principal Investigator (10%), Study Factors Associated with Perinatal Transmission of HIV - Part of State Perinatal AIDS Project. State of Texas, $ 100,000 per year for project period: Principal Investigator (10%), Evaluation of Minority and Community-Based HIV Prevention Project. Over the Hill Inc. via Center for Disease Control and Prevention, Total cost of $121,543 for 09/01/1989-8/31/1991. Co-investigator and Education Program Development & Epidemiology Consultant (15%), Training Grant for AIDS Regional Education and Training Center, Human Resource and Administration Service (HRAS). Total cost of $3,000,000 for project period of 09/01/1988-8/31/1991. (Principal Investigator: Richard Grimes, Ph.D.). Co-Principal Investigator, Genetic Determinants of Outcome in HBV Infections- Taiwan Project. National Cancer Institute, Total cost of $ 60,000 for project period; ; and total cost of $50,000 for project period: (Principal Investigator: R. Palmer Beasley, M.D.) Co-Principal Investigator, Recombinant Hepatitis B Vaccine - immunogenicity in infants-taiwan Project. Merck Sharp & Dohme Research Laboratories, Total cost of $248,550 for project period: (Principal Investigator: R. Palmer Beasley, M.D.) Co-Principal Investigator, Long-term Follow-up of HBV Vaccines in Children-Taiwan Project. National Science Council, Taiwan. Total cost of $350,000 for project period of (Principal Investigator: R. Palmer Beasley, M.D.) Co- Principal Investigator, Alfa-fetal Protein Screening among HBsAg Carriers for Detection of Small Hepatocellular Carcinoma-Taiwan Project, National Health Ministry & National Science Council, Taiwan. Project period (Principal Investigator: R. Palmer Beasley, M.D.) B. Pending Research Support. Co-Investigator (5%), Integrated Molecular and Affiliation Network Analysis of HIV Transmission. NIH, R21, project period of (Principal Investigator: Kayo December 8,

7 Fujimoto, PhD) C. Publications Multi-Principal Investigator (15%), CITAR-HanoiSPH for Advanced Training on HIV Research. National Institute of Health/Fogarty International Center, Project period of (Multi-Principal Investigator: Lu-Yu Hwang, MD) Journals (Peer reviewed): student author indicated by underline leadership role indicated by asterisk* 1. Hwang LY, Lue HC: Total anomalous pulmonary venous return - clinical analysis of 15 cases. Acta Pediat Sinica, 19:26-35, Hwang LY, Lee CY, Shen YZ: Purulent meningitis in children - part I. Epidemiology and clinical analysis of 287 cases. Acta Pediat Sinica, 19: , Hwang LY, Shen YZ, Lee CY: Purulent meningitis in children - part II. A long- term neurological follow-up study. Acta Pediat Sinica, 19: , Chen SH, Hwang LY, Wu HS, Huang SZ, Chen CH, Lee TC: Serum thyroxin, triodothyronine, T3 uptake and thyroid stimulating hormone concentrations in infancy, childhood, adolescence and pediatric thyroid disorders. Journal of Formosan Medical Association, 79: , PMID: R. Palmer Beasley, Lu-Yu Hwang, Chia-Chin Lin, Cladd E. Stevens, Kwei-Yun Wang, Tsu-Shen Sun, Fong-Jou Hsieh, Wolf Szmuness: Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Lancet, 2: , PMID: R. Palmer Beasley, Lu-Yu Hwang, Chia-Chin Lin, and Chia-Siang Chien: Hepatocellular carcinoma and HBV: A prospective study of 22,707 men in Taiwan. Lancet, 2: , PMID: R. Palmer Beasley, Chia-Chin Lin, Lu-Yu Hwang (1981): The risk of hepatocellular carcinoma in hepatitis B virus infections: a prospective study in Taiwan.. In: W Szmuness, HJ Alter, JE Maynard (eds.), Viral Hepatitis, 1981 International Symposium, The Franklin Institute Press, Philadelphia, PA, p Cladd E. Stevens, R. Palmer Beasley, Chia-Chin Lin, Lu-Yu Hwang, Tsu-Sen Sun, Fong-Jo Hsieh, Kwei-Yun Wang, Wolf Szmuness (1981): Perinatal hepatitis B virus infection: use of hepatitis B immune globulin. In: W Szmuness, HJ Alter, JE Maynard (eds.), Viral Hepatitis, 1981 International Symposium, The Franklin Institute Press, Philadelphia, PA, p Lu-Yu Hwang: Hepatitis B vaccine. Current Medical Digest, 69:5-19, 70:7-15, R. Palmer Beasley, and Lu-Yu Hwang: Measles vaccination not interfered with by hepatitis immune globulin. Lancet, 1:161, PMID: R. Palmer Beasley, I-Sen Shiao, Tzee-Chung Wu, Lu-Yu Hwang: Hepatoma in an HBsAg carrier - 7 years after perinatal infection. Journal of Pediatrics, 101:83-84, PMID: December 8,

8 12. R. P. Beasley, L.-Y Hwang, C.-C. Lin, M.-L Leu, C.E. Stevens, W. Szmuness, and K.-P Chen: Incidence of hepatitis B virus infections in preschool children in Taiwan. Journal of Infectious Disease, 146: , PMID R. Palmer Beasley, Chia-Chin Lin, Chia-Siang Chien, Chien-Jen Chen, and Lu-Yu Hwang: Geographic distribution of HBsAg carriers in China. Hepatology, 2: , PMID: R. Palmer Beasley, and Lu-Yu Hwang (1982): Non-A non-b hepatitis in Taiwan. In: F Deinhardt ed. Viral hepatitis: Second International Max von Pettenkofer Symposium, The Marcel Dekker, Inc., p R. Palmer Beasley, and Lu-Yu Hwang (1982): Vaccine studies in Chinese children in Taiwan. In: F Deinhardt ed. Viral Hepatitis: Second International Max von Pettenkofer Symposium. The Marcel Dekker, Inc., p Beasley RP, Hwang LY, Szmuness W, Stevens CE, Lin CC, Hsieh FJ, Wang KY, Sun TS. HBIG prophylaxis for perinatal HBV infections--final report of the Taiwan trial Dev Biol Stand. 1983;54: PMID: R. Palmer Beasley, Lu-Yu Hwang, Chia-Chin Lin, Yuan-Chin Ko, Shing-Jer Twu: Incidence of hepatitis among students at a university in Taiwan. American Journal of Epidemiology, 117: , PMID R. Palmer Beasley, and Lu-Yu Hwang: Postnatal infectivity of HBsAg carrier mothers. Journal of Infectious Disease, 147: , PMID Lu-Yu Hwang, R. Palmer Beasley, Czau-siung Yang, Liang-chu Hsu, Kung-pei Chen: Incidence of hepatitis A virus (HAV) infections in children in Taiwan. Intervirology, 20: , PMID: Lu-Yu Hwang, R. Palmer Beasley, Cladd E. Stevens, and the late Wolf Szmuness:: Immunogenicity of HBV vaccine (Hepatavax B) II. Response of healthy Chinese children. Vaccine, 1:10-12, PMID: George Chiun-Yun Lee, Lu-Yu Hwang, R. Palmer Beasley, Shen-Hyi Chen, and Tzu- Yao Lee: Immunogenicity of HBV vaccine in healthy Chinese newborns. Journal of Infectious Disease, 148: , PMID: R. Palmer Beasley, Lu-Yu Hwang, Cladd E. Stevens, Chia-Chin Lin, Fon-Jou Hsieh, Kwei-Yu Wang, Tsu-Shen Sun, and Wolf Szmuness: Efficacy of hepatitis B Immune Globulin (HBIG) for prevention of perinatal transmission of the HBV carrier state: Final report of a randomized double-blind placebo controlled trial. Hepatology, 3: , PMID: R. Palmer Beasley, Lu-Yu Hwang, George Chin-Yun Lee, Chung-Chi Lan, Chen- Hsiung Roan, Fu-Yuan Huang, Chiung-Lin Chen: Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin (HBIG) in combination with HB vaccine first report of a randomized controlled trial. Lancet, 2: , PMID: R. Palmer Beasley, and Lu-Yu Hwang: Immunogenicity of HBV vaccine (Hepatavax B): Response of healthy adults. Western Journal of Medicine, 140: , PMID: PMCID: PMC December 8,

9 25. R. Palmer Beasley, and Lu-Yu Hwang: Hepatocellular carcinoma and hepatitis B Virus. Seminars in Liver Disease, 4: , PMID: R. Palmer Beasley, and Lu-Yu Hwang (1984) : Epidemiology of hepatocellular carcinoma. in GN Vyas, JL Dienstag, JH Hoofnagle (eds.), Viral Hepatitis and Liver Disease, Grune and Stratton, Inc., Florida, p R. Palmer Beasley, Lu-Yu Hwang (1984): Current status of hepatitis B vaccination in children. In SK Lam, CL Lai, EK Yeoh (eds.), Viral Hepatitis B Infection in the Western Pacific Region: Vaccine and Control, Hong Kong, p Lu-Yu Hwang, Michael Roggendorf, R. Palmer Beasley, and Friedrich Deinhardt: Perinatal transmission of hepatitis B virus: Role of maternal HBeAg and Anti-HBc IgM. Journal of Medical Virology, 15: , PMID: Jen-Yang Chen, Lu-Yu Hwang, R. Palmer Beasley, Chia-Shiang Chien, Czau-Siung Yang: Antibody response to Epstein- Barr Virus-Specific DNase in thirteen patients with nasopharyngeal carcinoma in Taiwan: A retrospective study. Journal of Medical Virology, 16:99-105, PMID: Hey-Chi Hsu, Jin-Chuan Sheu, Yun-Ho Lin, Ding-Shinn Chen, Chue-Shue Lee, Lu-Yu Hwang, and R. Palmer Beasley: Prognostic histological features of resected small hepatocellular carcinoma (HCC) in Taiwan: A comparison with resected large HCC. Cancer, 56: , PMID: R. Palmer Beasley, and Lu-Yu Hwang: Abnormal immunologic response to hepatitis B in two brothers: A genetic effect? Journal of Infectious Disease, 152(6):1356, PMID: Nunilon E. Sy, Virginia Basaca-Sevilla, Tagumpay Esguerra, R. Palmer Beasley, Lu-Yu Hwang, and John H. Cross: HBsAg and HBeAg markers among pregnant women in Manila, Philippines. Transactions of the Royal Society of Tropical Medicine and Hygiene, 80: , PMID: Chu-Shue Lee, Jue-Low Sung, Lu-Yu Hwang, Jin-Chuan Sheu, Ding-Shinn Chen, Tien-Yu Lin, and R. Palmer Beasley: Surgical treatment of 109 cases of symptomatic and asymptomatic hepatocellular carcinoma. Surgery, 99(4): , PMID: Fen-Fen Wu, Lu-Yu Hwang, Chiun-Yun Lee, Chiun-Yun Hsu, Chiun-Fu Chen, His- Ping Kau, and R. Palmer Beasley: Primary evaluation of nationwide immunization against hepatitis in high risk infants. Journal of Formosan Medical Association, 86: , PMID: Michael Roggendorf, Lu-Yu Hwang, R. Palmer Beasley, Pao-Huei Chen, Tong-Chau Chen, Kwan-Re Lo, and Friedrich Deinhardt: Anti- HBc IgM in hepatocellular carcinoma and cirrhosis in Taiwan. Journal of Hepatology, 5: , PMID: Mei-Hwei Chang, Lu-Yu Hwang, Hey-Chi Hsu, Chin-Yun Lee, and R. Palmer Beasley: Prospective follow-up of asymptomatic hepatitis B virus carrier children infected in the perinatal period: Clinical and liver histological studies. Hepatology, 8:374-7, PMID: December 8,

10 37. Ernest Song, Michael Kew Lu-Yu Hwang, and R. Palmer Beasley: Epidemiology of hepatitis B in South African Chinese. American Journal of Epidemiology, 128: , PMID: Chu-Shue Lee, Lu-Yu Hwang, R. Palmer Beasley, Hey-Chi Hsu, Hau-Shan Lee, and Tien-Yu Lin: Prognostic factor for small hepatocellular carcinoma patients. Acta Chirugica Scandinavia, 154: , PMID: Lu-Yu Hwang, R. Palmer Beasley: Hepatitis B virus - the major etiology of hepatocellular carcinoma. Cancer Bulletin, 40: , L. Y. Hwang, R.P. Beasley, M.P. Busch, P.K. Lane, and G.N. Vyas: Human Immunodeficiency virus seroprevalence among blood products recipients prior to transfusion in San Francisco. Transfusion, 29: , PMID: Jen-Yang Chen, Chien-Jen Chen, Mei-Ying Liu, Show-Mei Cho, Mow-Ming Hsu, Tsong-Chou Lynn, Ti Shie, Shie-Mien Tu, R. Palmer Beasley, Lu-Yu Hwang, Hong- Hsin Lee, Shiow-Ling Kuo, and Czau-Siung Yang: Antibody to Epstein-Barr virusspecific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan. Journal of Medical Virology, 27: , PMID: Chin-Yun Lee, Lu-Yu Hwang, R. Palmer Beasley: Low-Dose hepatitis B vaccine. Lance, ii: , PMID: Lu-Yu Hwang, Chin-Yun Lee, R. Palmer Beasley (1990): Five year follow-up of HBV vaccination with plasma derived vaccine in neonates: evaluation of immunogenicity and efficacy against perinatal transmission. In: FB Hollinger, SM Lemon, HS Margolis (eds.), Viral Hepatitis -1990, The Williams & Wilkins, p R. Palmer Beasley and Lu-Yu Hwang (1990): Overview on the Epidemiology of Hepatocellular Carcinoma. In: FB Hollinger, SM Lemon, HS Margolis (eds.), Viral Hepatitis -1990, The Williams & Wilkins, p Chin-Yun Lee, Lu-Yu Hwang, R. Palmer Beasley, Chiun-Fu Chen, Fu-Yan Huang, Shou-Chen Wu, Chong-Chi Lan (1990): Immunogenicity and protective efficacy on low-dose hepatitis B vaccine in newborns of HBsAg-carrier mothers. In: FB Hollinger, SM Lemon, HS Margolis (eds.), Viral Hepatitis -1990, The Williams & Wilkins, p Lu-Yu Hwang: Specific Travel Concerns: Pediatric Prophylaxis, Diagnosis, and Treatment of Hepatitis A, B, C, D and E. Seminar in Pediatric Infectious Disease, 3: 1-36, Robert D. Burk, Lu-Yu Hwang, Gloria Y.F. Ho, David A Sharfritz, and Palmer Beasley: Outcome of perinatal hepatitis B virus exposure is dependent on maternal viral load. Journal of Infectious Disease, 170: , PMID: Dean M, Stephensn JC, Winkler C, Lomb D, Ramsburg M, Boaze R, Stewart C, Charbonneau L, Goldman D, Albaugh B, Geodert J, Beasley RP, Hwang LY, Buckbinder S, Kaslow R, Obrams I, Gomperts E, Dondield S, Johnson P, Eichelberger M & O'Brien S: Polymorphic admixture typing in human ethnic populations. American Journal of Human Genetics, 55: , PMCID: PMC Risser, J., Rabeneck, L., Hwang, L.-Y: A Comparison of Population-Specific Fat- December 8,

11 Free Mass and Body-Cell Mass Prediction Equations in HIV-Infected Men. Journal of the American Dietetic Association 95, Issue 9 SUPPL.1995, Pages A15 50 J.M.H. Risser; L. Rabeneck; L.-Y. Hwang, Anti-viral medication is protective of lean body mass in a cross sectional study of wasting in hiv-infected men, Journal of Investigative Medicine, 44 (3): 251, 1996, Pages 251a 51 Nathaniel H Smith, and Lu-Yu Hwang*: Risk Factors for HIV in pregnant women. International Journal of STDs and AIDS, 7: , PMID: William L. Risser, and Lu-Yu Hwang*: Problems in the current case definition of congenital syphilis. Journal of Pediatrics, 129: , PMID: William L. Risser, and Lu-Yu Hwang*: Congenital syphilis in Harris County, TX : surveillance, diagnosis, incidence, & risk. International Journal of STDs and AIDS, 8: , PMID: Snachit Maruti, Lu-Yu Hwang*, Michael Ross, Lori Leonard, John Paffel, and Linda Hollins: Epidemiology of early syphilis in Houston, Texas, Journal of Sexual Transmitted Diseases, 24: , PMID: Rachel L. Richesson, Lu-Yu Hwang*: The impact of the 1993 expanded CDC AIDS surveillance case definition in Texas. Texas Medicine, 94:56-63, PMID: Xifeng Wu, Jun Gu, Yehuda Patt, Manal Hassan, Margaret R. Spitz, R. Palmer Beasley, and Lu-Yu Hwang*: Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma. Cancer Epidemiology and Biomarkers Prevention, 7: , PMID: Yetman RJ, Risser WL, Barth BA, Risser JM, Hwang LY: Problems in physician classification and reporting of congenital syphilis. International Journal of STDs and AIDS, 9: 765-8, PMID: Michael Ross, Lu-Yu Hwang, Lori Leonard, Ming Teng and Lawrence Duncan: Sexual behavior, STDs and Crack Cocaine Use in a Crack House Population. International Journal of STDs and AIDS, 10: , PMID: M. Cecilia Di Pentima, Lu-Yu Hwang*, Claire M. Skeeter, and MorvenEdwards: Prevalence of Trypansoma Cruzi infection (Chagas Disease) among Hispanic pregnant women in Houston TX. Clinical Infectious Diseases, 28:1281-5, PMID: Judy S. Wu, Lu-Yu Hwang*, Karen Goodman, and R. Palmer Beasley: Hepatitis B vaccination in high-risk infants: 10-year follow-up. Journal of Infectious Disease, 179: , PMID: Jan M.H. Risser, Lu-Yu Hwang*, William L. Risser, Linda Hollins, and John Paffel: The epidemiology of syphilis in the waning years of an epidemic: Houston, TX Journal of Sexual Transmitted Diseases, 26: , PMID: Catherine D Cooksley, Lu-Yu Hwang*, D. Kim Waller, and Charles Ford: HIV- Related Malignancy- a community based study using a linkage of cancer registry and HIV registry data. International Journal of STDs and AIDS, 12: , PMID: December 8,

12 63. Lu-Yu Hwang, Michael Ross, Carolyn Zack, Lara Bull, Kathie Rickman, and Marsha Holleman: The prevalence of sexually transmissible infections and associated risk factors in drug abuse populations. Clinical Infectious Diseases, 31:920-6, PMID: Manal Hassan,hr 64. Manal Hassan, Ashraf S. Zaghloul, Hashem B. El-Serag, Osama Soliman, Yehuda Patt, Cynthia L. Chappell, R. Palmer Beasley, and Lu-Yu Hwang*: The role of hepatitis C in hepatocellular carcinoma: A case-control study among Egyptian patients. Journal of Clinical Gastroenterology, 33(2): , PMID: Catherine D. Cooksley, Lu-Yu Hwang*, Charles E. Ford: Registry linkage to study cancer in persons infected with HIV. Journal of Registry Management, 28:82-88, Janet Baseman, Lori Leonard, Michael Ross, and Lu-Yu Hwang: Acceptance of syphilis screening among residents of high STD-risk Houston communities. International Journal of STDs and AIDS, 12: , PMID: Michael W Ross, Lu-Yu Hwang, LY, Carolyn Zack, Lara Bull, and Mark L Williams: Sexual risk behaviors and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. International Journal of STDs and AIDS, 13: , PMID: Lyn Finelli, Thomas P. Farley, James J. Gibson, Carol Langley, Lu-Yu Hwang, and William C.Levine: Prevalence monitoring in syphilis surveillance: Results from a multi center research program. Sexually Transmitted Diseases, 29 (12): , PMID: Manal M. Hassan, 69. Manal M. Hassan,Lu-Yu Hwang*, Chiq J. Hatten, Mark Swaim, Donghui Li, James L. Abbruzzese, Palmer Beasley, and Yehuda Patt: Risk factors for hepatocellelar carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology, 36: , PMID: G. D Souza G, 70. G G. D Souza G, R. Arafat, L. Hwang*, C. Cunningham, S Shah, and K. Reynolds:Crosssectional survey of the extent and indicators of hepatitis C virus infection in Houston Department of Health and Human Services STD clinics. Journal of Viral Hepatitis, 10: , PMID: F.T. O'Donnell, F.M. Munoz, R.L. Atmar, L.Y. Hwang, G.J. Demmler, and W.P. Glezen: Epidemiology And Molecular Characterization Of Co-Circulating Influenza A/H3n2 Virus Variants In Children: Houston, Texas, Epidemiology and Infection, 130: , PMID: Jennifer R. Kramer, 72. Jennifer R. Kramer, Thomas P. Giordano, Julianne Souchek, Peter Richardson, Lu-Yu Hwang*, and Hashem B. El-Serag: The effect of HIV co-infection on the risk of cirrhosis and hepatocellular carcinoma in US veterans with hepatitis C. American Journal of Gastroenterology, 100(1):56-63, PMID: Hua Zhao, H. Barton Grossman, George L. Delclos, Lu-Yu Hwang, Catherine Troisi, Robert M. Chamberlain, Marsha Chenoweth, Hulfeng Zhang, Margaret R. Spitz, Xifeng Wu: Increased plasma levels of angiogenin and risk of bladder cancer from initiation to recurrence. Cancer, (2005), 104(1):30-5. PMID: Kelvin Stancoven, Lu-Yu Hwang*, and Catherine Troisi: Significance of Anti-HBc in December 8,

Case Finding for Hepatitis B and Hepatitis C

Case Finding for Hepatitis B and Hepatitis C Case Finding for Hepatitis B and Hepatitis C John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Atlanta, Georgia, USA Division of Viral Hepatitis National Center

More information

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016 William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016 Advisory Committee on Immunization Practices (ACIP) The recommendations to be discussed are primarily those of the ACIP composed of 15

More information

National Health Burden of CLD in Italy

National Health Burden of CLD in Italy National Health Burden of CLD in Italy 11,000 deaths due to liver cirrhosis or HCC in 2006 Direct costs for the National Health System for treating CLD patients: 420 M / year for hospital care 164 M /

More information

Are Booster Doses of Hepatitis B Vaccine Necessary?

Are Booster Doses of Hepatitis B Vaccine Necessary? Are Booster Doses of Hepatitis B Vaccine Necessary? Current CDC Recommendations And Gaps in Knowledge Division of Viral Hepatitis Centers for Disease Control and Prevention, USA Current United States Recommendations

More information

Hepatitis at a national level: government perspectives

Hepatitis at a national level: government perspectives Hepatitis at a national level: government perspectives Presenter: Dr Shin Young-Soo Regional Director WHO Western Pacific Panel The Honourable Dr. David Sergeenko Minister of Health, Labour and Social

More information

NOTIFIABLE. Infectious Disease Assessment for Migrants 2015 - 27 - RECOMMENDATIONS. Offer test (HBsAg and anti-hbc) to: Vaccinate:

NOTIFIABLE. Infectious Disease Assessment for Migrants 2015 - 27 - RECOMMENDATIONS. Offer test (HBsAg and anti-hbc) to: Vaccinate: 5.2 Hepatitis B NOTIFIABLE RECOMMENDATIONS Offer test (HBsAg and anti-hbc) to: = All new migrants originating from countries with a HBsAg prevalence of 2% = Household and sexual of identified acute or

More information

HEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis

HEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis HEPATITIS WEB STUDY Acute C Virus Infection: Epidemiology, Clinical Features, and Diagnosis H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School

More information

Evidence-Based Practice for Public Health Identified Knowledge Domains of Public Health

Evidence-Based Practice for Public Health Identified Knowledge Domains of Public Health 1 Biostatistics Statistical Methods & Theory Evidence-Based Practice for Public Health Identified Knowledge Domains of Public Health General Public Health Epidemiology Risk Assessment Population-Based

More information

A Ministry of the Archdiocese of Galveston-Houston A United Way Agency

A Ministry of the Archdiocese of Galveston-Houston A United Way Agency A Ministry of the Archdiocese of Galveston-Houston A United Way Agency Integrated Multidsciplinary Approach to Adapt Routine HIV Screening in a Safety Net Clinic Setting Sherri D. Onyiego MD, PhD Baylor

More information

When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII)

When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII) XI. OCCUPATIONAL EXPOSURES TO HEPATITIS B AND C RECOMMENDATION: When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII) The risk of transmission

More information

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient

More information

Viral Hepatitis Case Report

Viral Hepatitis Case Report Page 1 of 9 Viral Hepatitis Case Report Perinatal Hepatitis B Virus Infection Michigan Department of Community Health Communicable Disease Division Investigation Information Investigation ID Onset Date

More information

2015 Outpatient Chronic Hepatitis B Management

2015 Outpatient Chronic Hepatitis B Management 2015 Outpatient Chronic Hepatitis B Management Hepatitis B Hepatitis B Info 70% of acute infections are subclinical More severe symptoms when in addition to other liver disease Fulminant Hepatitis

More information

CURRICULUM VITAE. NAME: Huang,Po-Hao OFFICE ADDRESS: EDUCATION: EMPLOYMENT RECORD: PROFFESIONAL AFFILIATIONS: 黃 柏 豪

CURRICULUM VITAE. NAME: Huang,Po-Hao OFFICE ADDRESS: EDUCATION: EMPLOYMENT RECORD: PROFFESIONAL AFFILIATIONS: 黃 柏 豪 CURRICULUM VITAE NAME: Huang,Po-Hao 黃 柏 豪 OFFICE ADDRESS: China Medical University Hospital, No. 2, Yuh-Der Road, Taichung, Taiwan, R.O.C. 中 國 醫 藥 大 學 附 設 醫 院, 內 科 部 風 溼 免 疫 科 台 灣 台 中 市 北 區 育 德 路 2 號 EDUCATION:

More information

Hepatitis C Infections in Oregon September 2014

Hepatitis C Infections in Oregon September 2014 Public Health Division Hepatitis C Infections in Oregon September 214 Chronic HCV in Oregon Since 25, when positive laboratory results for HCV infection became reportable in Oregon, 47,252 persons with

More information

The Epidemiology of Hepatitis A, B, and C

The Epidemiology of Hepatitis A, B, and C The Epidemiology of Hepatitis A, B, and C Jamie Berkes M.D. University of Illinois at Chicago jberkes@uic.edu Epidemiology: Definitions The study of the incidence and prevalence of diseases in large populations

More information

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND EPIDEMIOLOGY OF HEPATITIS B IN IRELAND Table of Contents Acknowledgements 3 Summary 4 Introduction 5 Case Definitions 6 Materials and Methods 7 Results 8 Discussion 11 References 12 Epidemiology of Hepatitis

More information

Cultural Competency: HBV Prevention and Control in the Asian American Communities

Cultural Competency: HBV Prevention and Control in the Asian American Communities Cultural Competency: HBV Prevention and Control in the Asian American Communities Samuel So, MD 苏 启 深 教 授 Asian health activist Asian Liver Center Lui Hac Minh Professor of Surgery Stanford University

More information

Thesis: Neighborhood Poverty & Gender Inequality: The Context of Individual Sexual Risk Behaviors for Sexually Transmitted Infections

Thesis: Neighborhood Poverty & Gender Inequality: The Context of Individual Sexual Risk Behaviors for Sexually Transmitted Infections SHELITA G. MERCHANT PERSONAL DATA Business Address: Department of Epidemiology and Biostatistics School of Public Health and Health Services George Washington University 2021 K Street, NW, Room 826 Washington,

More information

Prospects for Vaccines against Hepatitis C Viruses. T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS

Prospects for Vaccines against Hepatitis C Viruses. T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS Prospects for Vaccines against Hepatitis C Viruses T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS HCV Vaccine Prevention strategies Protective immunity Barriers and solutions Vaccine candidates

More information

Placing Nation on the Path Toward the Elimination of Hepatitis C

Placing Nation on the Path Toward the Elimination of Hepatitis C Placing Nation on the Path Toward the Elimination of Hepatitis C John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Division of Viral Hepatitis National Center for

More information

JENNIFER MEGHAN STEWART, PHD, RN 418 Curie Blvd., Claire Fagin Hall, Philadelphia, PA 19104 (215) 746-8817 (o) (773) 577-9902 stewj@nursing.upenn.

JENNIFER MEGHAN STEWART, PHD, RN 418 Curie Blvd., Claire Fagin Hall, Philadelphia, PA 19104 (215) 746-8817 (o) (773) 577-9902 stewj@nursing.upenn. JENNIFER MEGHAN STEWART, PHD, RN 418 Curie Blvd., Claire Fagin Hall, Philadelphia, PA 19104 (215) 746-8817 (o) (773) 577-9902 stewj@nursing.upenn.edu EDUCATION PhD University of Illinois at Chicago College

More information

Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results

Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results David W. Forrest, Ph.D. Marlene LaLota, M.P.H. John-Mark Schacht Gabriel A. Cardenas, M.P.H. Lisa Metsch, Ph.D. National HIV Behavioral

More information

BACKGROUND MEDIA INFORMATION Fast facts about liver disease

BACKGROUND MEDIA INFORMATION Fast facts about liver disease BACKGROUND MEDIA INFORMATION Fast facts about liver disease Liver, or hepatic, disease comprises a wide range of complex conditions that affect the liver. Liver diseases are extremely costly in terms of

More information

GUIDELINES FOR VIRAL HEPATITIS SURVEILLANCE AND CASE MANAGEMENT

GUIDELINES FOR VIRAL HEPATITIS SURVEILLANCE AND CASE MANAGEMENT GUIDELINES FOR VIRAL HEPATITIS SURVEILLANCE AND CASE MANAGEMENT January 2005 Guidelines for Viral Hepatitis Surveillance and Case Management Ordering information To order a copy of this manual, write to:

More information

September 17, 2010. Dear Secretary Sebelius:

September 17, 2010. Dear Secretary Sebelius: September 17, 2010 Secretary Kathleen Sebelius Department of Health and Human Services Hubert H. Humphrey Building 200 Independence Avenue, SW Washington, DC 20201 RE: Comments on OCIIO- 9992- IFC, Interim

More information

FEDERAL BUREAU OF PRISONS REPORT ON INFECTIOUS DISEASE MANAGEMENT

FEDERAL BUREAU OF PRISONS REPORT ON INFECTIOUS DISEASE MANAGEMENT FEDERAL BUREAU OF PRISONS REPORT ON INFECTIOUS DISEASE MANAGEMENT What is the purpose of this report? The purpose of this report is to present the administrative policies and clinical guidelines for the

More information

Management of Hepatitis C: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians

Management of Hepatitis C: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians Performance ment Management of Hepatitis C: Review of the Performance s by the Performance ment Committee of the American College of Physicians Writing Committee Amir Qaseem, MD, Andrew Dunn, MD, Stephen

More information

Recommendations for the Identification of Chronic Hepatitis C virus infection Among Persons Born During 1945-1965

Recommendations for the Identification of Chronic Hepatitis C virus infection Among Persons Born During 1945-1965 Recommendations for the Identification of Chronic Hepatitis C virus infection Among Persons Born During 1945-1965 MMWR August 17, 2012 Prepared by : The National Viral Hepatitis Technical Assistance Center

More information

Assistant Prof. Dr. Kim Yun Jin 金 渊 真 助 理 教 授

Assistant Prof. Dr. Kim Yun Jin 金 渊 真 助 理 教 授 Assistant Prof. Dr. Kim Yun Jin 金 渊 真 助 理 教 授 Position 职 称 : Head, Department of Traditional Chinese Medicine 中 医 药 学 院 中 医 系 系 主 任 Physician, Southern TCM Centre 南 方 中 医 诊 疗 中 心 驻 诊 医 师 Academic Qualification

More information

3/25/2014. April 3, 2014. Dennison MM, et al. Ann Intern Med. 2014;160:293 300.

3/25/2014. April 3, 2014. Dennison MM, et al. Ann Intern Med. 2014;160:293 300. April 3, 2014 3.6 million persons ever infected; 2.7 million chronic infections 1 Up to 75% unaware of status Transmitted through percutaneous exposure to infected blood Injection drug use (IDU) is the

More information

Academic and Visa Administration - Trainee. 2012-2013 Annual Report

Academic and Visa Administration - Trainee. 2012-2013 Annual Report Annual Report Trainee and Alumni Affairs 2012-2013 Annual Report Summary of Trainee Metrics and Growth Patterns for 2012-2013 Page Table 1 Annual Educational Trainee Metric Report 1 Table 2 Five-Year Educational

More information

Curriculum Vitae. 2009. Betty Irene Moore School of Nursing Postdoctoral Fellow. University of California, Davis.

Curriculum Vitae. 2009. Betty Irene Moore School of Nursing Postdoctoral Fellow. University of California, Davis. Curriculum Vitae, PhD, APRN-BC, PNP 523 Mockingbird Place Davis, CA 95616 530-753-6822 / 400-2866 Email: dibaker@csus.edu EDUCATION 2009. Betty Irene Moore School of Nursing Postdoctoral Fellow. University

More information

CURRICULM VITAE. Michelle D. Evans-Chase, PhD 1131 Simpson Avenue, 2 nd fl. Ocean City, NJ 08226 PH (609) 602-3792 email: evans-chase@rowan.

CURRICULM VITAE. Michelle D. Evans-Chase, PhD 1131 Simpson Avenue, 2 nd fl. Ocean City, NJ 08226 PH (609) 602-3792 email: evans-chase@rowan. CURRICULM VITAE August 2015 Michelle D. Evans-Chase, PhD 1131 Simpson Avenue, 2 nd fl. Ocean City, NJ 08226 PH (609) 602-3792 email: evans-chase@rowan.edu EDUCATION PhD University of Pennsylvania, Philadelphia

More information

Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services

Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services ADP Training Conference, Sacramento, August 21, 2012 Rachel McLean, MPH, CA Dept. of Public

More information

Curriculum Vitae. Cheng-Ching (Hiya) Liu

Curriculum Vitae. Cheng-Ching (Hiya) Liu Curriculum Vitae Cheng-Ching (Hiya) Liu 1.0 DEMOGRAPHIC & CONTACT INFORMATION Assistant Professor Michigan State University College of Nursing A130 Life Science 1355 Bogue Street East Lansing, MI 48825-1109

More information

Education. University of Texas, Austin, TX August 2002-August 2006 Degree in: Government; minor in history. Research Interests

Education. University of Texas, Austin, TX August 2002-August 2006 Degree in: Government; minor in history. Research Interests Education Casey Philip Durand, PhD MPH Assistant Professor University of Texas School of Public Health 7000 Fannin St., #2664 Houston, TX 77030 713-500-9685 Casey.P.Durand@uth.tmc.edu PhD University of

More information

University of Texas at Austin Austin, Texas 2001-2005 Ph.D, Health Education and Behavior, Minor in Gerontology

University of Texas at Austin Austin, Texas 2001-2005 Ph.D, Health Education and Behavior, Minor in Gerontology Education: Oregon Health and Science University Portland, Oregon 2005-2008 Post Doctorate, Disability and Health Promotion Rehabilitation Research Training Center-Health & Wellness Oregon Institute on

More information

Commonly Asked Questions About Chronic Hepatitis C

Commonly Asked Questions About Chronic Hepatitis C Commonly Asked Questions About Chronic Hepatitis C From the American College of Gastroenterology 1. How common is the hepatitis C virus? The hepatitis C virus is the most common cause of chronic viral

More information

ROYAL HOSPITAL FOR WOMEN

ROYAL HOSPITAL FOR WOMEN HEPATITIS B POSITIVE MOTHERS AND THEIR BABIES This LOP is developed to guide clinical practice at the Royal Hospital for Women. Individual patient circumstances may mean that practice diverges from this

More information

HPTN 073: Black MSM Open-Label PrEP Demonstration Project

HPTN 073: Black MSM Open-Label PrEP Demonstration Project HPTN 073: Black MSM Open-Label PrEP Demonstration Project Overview HIV Epidemiology in the U.S. Overview of PrEP Overview of HPTN HPTN 061 HPTN 073 ARV Drug Resistance Conclusions Questions and Answers

More information

CURRICULUM VITAE. Veterans Administration Medical Center, Psychiatry Service 1984-1986 San Francisco, CA Fellow in Substance Use Disorders

CURRICULUM VITAE. Veterans Administration Medical Center, Psychiatry Service 1984-1986 San Francisco, CA Fellow in Substance Use Disorders CURRICULUM VITAE H. Westley Clark, M.D., J.D., M.P.H., CAS, FASAM Director, Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration Department of Health & Human Services

More information

PERINATAL AND CHILDHOOD HEPATITIS.. WHAT ABOUT THE CHILDREN?

PERINATAL AND CHILDHOOD HEPATITIS.. WHAT ABOUT THE CHILDREN? PERINATAL AND CHILDHOOD HEPATITIS.. WHAT ABOUT THE CHILDREN? John T. Stutts, MD, MPH University of Louisville School of Medicine Department of Pediatrics Division of Pediatric Gastroenterology, Hepatology

More information

2012 Assistant Professor, School of Criminal Justice, University at Albany, State University of New York

2012 Assistant Professor, School of Criminal Justice, University at Albany, State University of New York October 2013 HEATHER MARIE WASHINGTON CURRICULUM VITAE School of Criminal Justice Office: 518.591.8737 University at Albany Fax: 518.442.5380 135 Western Avenue, Draper 219 Albany, NY 12222 E-mail: hmwashington@albany.edu

More information

CME Article Hiv Disease Surveillance

CME Article Hiv Disease Surveillance CME Article Hiv Disease Surveillance hiv disease surveillance cme Collaboration between Medicine and Public Health Sindy M. Paul, md, mph; Helene Cross, phd; Linda Dimasi, mpa; Abdel R. Ibrahim, phd; and

More information

CURRICULUM VITAE Kathryn Lenore Garcia Lenberg, M.P.H., Ph.D.

CURRICULUM VITAE Kathryn Lenore Garcia Lenberg, M.P.H., Ph.D. Contact Information Business: 9426 Indian School Rd. NE Ste. 1 Albuquerque, NM 87112 Office Phone: (505) 345-6100 ext. 11 Email: researchdivision@behaviortherapy.com CURRICULUM VITAE Kathryn Lenore Garcia

More information

The Natural History of Chronic Hepatitis B Virus Infection

The Natural History of Chronic Hepatitis B Virus Infection The Natural History of Chronic Hepatitis B Virus Infection Brian J. McMahon, M.D. 1 ABSTRACT Three stages of chronic hepatitis B virus (HBV) infection are recognized: the immune tolerant phase, the chronic

More information

3- Work Experiences: Head of a rural Health Center as a General Physician(for less than 1 year).

3- Work Experiences: Head of a rural Health Center as a General Physician(for less than 1 year). In the name of God Dr Chaman CV 1- Identifying information: First name: Reza Last name: Chaman Birth date: 1971 Work Place address: Shahroud University of Medical Sciences ( Assistant professor of Epidemiology,

More information

Public Health Services

Public Health Services Public Health Services FUNCTION The functions of the Public Health Services programs are to protect and promote the health and safety of County residents. This is accomplished by monitoring health status

More information

Prison and Jail Health January 18, 2007. Viewer Call-In. Evaluations. www.t2b2.org. Phone: 800-452-0662 Fax: 518-426-0696. 518-402-0330 www.t2b2.

Prison and Jail Health January 18, 2007. Viewer Call-In. Evaluations. www.t2b2.org. Phone: 800-452-0662 Fax: 518-426-0696. 518-402-0330 www.t2b2. Prison and Jail Health January 18, 2007 Guthrie S. Birkhead, M.D., M.P.H Director, AIDS Institute and Center for Community Health New York State Department of Health (NYSDOH) Lester N. Wright, M.D., M.P.H.

More information

NICHD s Pediatric, Adolescent, & Maternal AIDS Branch

NICHD s Pediatric, Adolescent, & Maternal AIDS Branch Friends of NICHD Webinar: NICHD s Pediatric, Adolescent, & Maternal AIDS Branch Lynne Mofenson, MD Branch Chief December 19, 2008 Please call in-dial: 888-517-2197 Code:7080363 Webinar Guidelines All participants

More information

CASL Symposium Hepatitis B Co-chairs: Carla Coffin and Mang Ma

CASL Symposium Hepatitis B Co-chairs: Carla Coffin and Mang Ma CASL Symposium Hepatitis B Co-chairs: Carla Coffin and Mang Ma Occult HBV Infection: Assessment and Clinical Significance D. Lorne Tyrrell Director, Li Ka Shing Institute of Virology University of Alberta

More information

Impact of natural boostering on long-term protection against hepatitis B after newborn (HBsAg + mothers) vaccination.

Impact of natural boostering on long-term protection against hepatitis B after newborn (HBsAg + mothers) vaccination. Impact of natural boostering on long-term protection against hepatitis B after newborn (HBsAg + mothers) vaccination Roznovsky Ludek Department of Infectious Diseases University Hospital Ostrava, Czech

More information

Chapter 1 Overview of Tuberculosis Epidemiology in the United States

Chapter 1 Overview of Tuberculosis Epidemiology in the United States Chapter 1 Overview of Tuberculosis Epidemiology in the United States Table of Contents Chapter Objectives.... 1 Progress Toward TB Elimination in the United States.... 3 TB Disease Trends in the United

More information

Sun Seog Kim, PhD, APRN-PC 365 PLANTATION STREET, SUITE 100 WORCESTER, MA 01655 TEL: 508-856-6384, FAX: 508-856-6426 E-MAIL: sun.kim@umassmed.

Sun Seog Kim, PhD, APRN-PC 365 PLANTATION STREET, SUITE 100 WORCESTER, MA 01655 TEL: 508-856-6384, FAX: 508-856-6426 E-MAIL: sun.kim@umassmed. 1 Sun Seog Kim, PhD, APRN-PC 365 PLANTATION STREET, SUITE 100 WORCESTER, MA 01655 TEL: 508-856-6384, FAX: 508-856-6426 E-MAIL: sun.kim@umassmed.edu CURRENT POSITION 08/02/2007 Present Assistant Professor,

More information

Adelbert B. James, PhD, MPH

Adelbert B. James, PhD, MPH 307 Andridge Court Cell: 678-699-1612 Suwanee, GA 30024 Email: ajames@abjhealthconsult.com EDUCATION: PhD Health Services, specializing in Community Health, Walden University, Minneapolis, MN 2003 Graduate

More information

Varicella and Varicella Vaccine

Varicella and Varicella Vaccine Varicella and Epidemiology and Prevention of Vaccine- Preventable Diseases Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition website at http://www.vaccineinformation.org/photos/index.asp

More information

Stefan R. Rowniak, PhD, RN, MS, FNP. University of California, San Francisco, CA. University of California, San Francisco, CA

Stefan R. Rowniak, PhD, RN, MS, FNP. University of California, San Francisco, CA. University of California, San Francisco, CA Stefan R. Rowniak, PhD, RN, MS, FNP EDUCATION 2010 2010 1991 1985 1979 1976 SF State University Seattle University Seattle, WA University of Washington Seattle, WA Post-Doctoral Student PhD, Nursing MSN,

More information

Strategies to Improve the HCV Continuum of Care:

Strategies to Improve the HCV Continuum of Care: Strategies to Improve the HCV Continuum of Care: Best Practices in Testing, Linkage to Care & Treatment Ronald O. Valdiserri, M.D., M.P.H. Deputy Assistant Secretary for Health, Infectious Diseases June

More information

Substance Abuse Treatment Evaluations and Interventions Program

Substance Abuse Treatment Evaluations and Interventions Program Substance Abuse Treatment Evaluations and Interventions Program Project Highlights: HIV Interventions in North Carolina Wendee Wechsberg, Ph.D. SATEI Program Director RTI International 3040 Cornwallis

More information

Viral Hepatitis A, B, and C

Viral Hepatitis A, B, and C Viral Hepatitis A, B, and C What is Hepatitis? Hepatitis means inflammation of the liver Elizabeth A. Bancroft, MD, SM Acute Communicable Disease Control County of Los Angeles Department of Public Health

More information

CURRICULUM VITAE. Yawen Li, M.S.W., Ph.D. School of Social Work San Diego State University. Fall, 2011

CURRICULUM VITAE. Yawen Li, M.S.W., Ph.D. School of Social Work San Diego State University. Fall, 2011 CURRICULUM VITAE Yawen Li, M.S.W., Ph.D. School of Social Work San Diego State University Fall, 2011 San Diego State University School of Social Work 5500 Campanile Drive, HH103 San Diego, CA 92182-4119

More information

João Silva de Mendonça, MD, PhD Infectious Diseases Service Hospital do Servidor Público Estadual São Paulo - Brazil

João Silva de Mendonça, MD, PhD Infectious Diseases Service Hospital do Servidor Público Estadual São Paulo - Brazil Brazilian Ministry of Health, Brazilian Society of Hepatology PAHO, Viral Hepatitis Prevention Board PART III SESSION 9 Prevention and control of Viral Hepatitis in Brazil HEPATITIS IN SPECIAL RISK GROUPS/

More information

CURRICULUM VITAE SHELDON OLIVER WATTS, PHD, MPH

CURRICULUM VITAE SHELDON OLIVER WATTS, PHD, MPH CURRICULUM VITAE SHELDON OLIVER WATTS, PHD, MPH SHELDON.WATTS@TEMPLE.EDU RESEARCH INTERESTS Chronic diseases and their risk factors in vulnerable populations; special interest in children, immigrants,

More information

Viral Hepatitis. 2009 APHL survey report

Viral Hepatitis. 2009 APHL survey report Issues in Brief: viral hepatitis testing Association of Public Health Laboratories May Viral Hepatitis Testing 9 APHL survey report In order to characterize the role that the nation s public health laboratories

More information

12/2/2015 HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE OBJECTIVES VIRAL HEPATITIS

12/2/2015 HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE OBJECTIVES VIRAL HEPATITIS HEPATITIS B AND HEPATITIS C BLOOD EXPOSURE DISEASE 101 ONLINE CONFERENCE SARAH WENINGER, MPH VIRAL HEPATITIS.STD.HIV PREVENTION COORDINATOR DECEMBER 3, 2015 OBJECTIVES Describe the populations that should

More information

The Clinical Content of Preconception Care: Alcohol, Tobacco, and Illicit Drug Exposures

The Clinical Content of Preconception Care: Alcohol, Tobacco, and Illicit Drug Exposures The Clinical Content of Preconception Care: Alcohol, Tobacco, and Illicit Drug Exposures by R. Louise Floyd, DSN, RN; Brian W. Jack, MD; Robert Cefalo, MD, PhD; Hani Atrash, MD, MPH; Jeanne Mahoney, BSN,

More information

Performance of a New-Generation Chemiluminescent Assay for Hepatitis B Surface Antigen

Performance of a New-Generation Chemiluminescent Assay for Hepatitis B Surface Antigen Clinical Chemistry 52:8 1592 1598 (2006) Other Areas of Clinical Chemistry Performance of a New-Generation Chemiluminescent Assay for Hepatitis B Surface Antigen Dan Chen 1* and Lawrence A. Kaplan 1 Background:

More information

Up to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data).

Up to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data). HIV Background, new developments, key strategies Drug Class Insight INTRODUCTION Human Immunodeficiency Virus (HIV) is the virus that can lead to Acquired Immunodeficiency Syndrome, or AIDS. No safe and

More information

Meena Abraham, DrPH, MPH Director of Epidemiology Services Baltimore City Health Department

Meena Abraham, DrPH, MPH Director of Epidemiology Services Baltimore City Health Department Meena Abraham, DrPH, MPH Director of Epidemiology Services Baltimore City Health Department 271 Neighborhood Statistical Areas 55 Community Statistical Areas 26 Zip Codes Characteristic Baltimore City

More information

Chronic Viral Hepatitis and Health Care Reform

Chronic Viral Hepatitis and Health Care Reform Chronic Viral Hepatitis and Health Care Reform The purpose of this report is to outline and describe the basic required elements of health care for persons with chronic viral hepatitis infections. BACKGROUND

More information

CURRICULUM VITAE. JUNGEUN Jay LEE, Ph.D.

CURRICULUM VITAE. JUNGEUN Jay LEE, Ph.D. 1 CURRICULUM VITAE JUNGEUN Jay LEE, Ph.D. CURRENT POSITION 2012 Present Visiting Assistant Professor Department of Nursing and Rehabilitation Sciences Angelo State University EDUCATION Degree Institution/Department

More information

About Medicine Specialists of Florida Hospital:

About Medicine Specialists of Florida Hospital: Welcome to Medicine Specialists of Florida Hospital. We look forward to serving you and your family in any way we can. Our physicians and staff strive to offer personalized care to each patient while maintaining

More information

Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid

Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid Epidemiology of Hepatitis C Infection Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid Worldwide Prevalence of Hepatitis C 10% No data available WHO.

More information

Preventive Care Recommendations THE BASIC FACTS

Preventive Care Recommendations THE BASIC FACTS Preventive Care Recommendations THE BASIC FACTS MULTIPLE SCLEROSIS Carlos Healey, diagnosed in 2001 The Three Most Common Eye Disorders in Multiple Sclerosis Blood Pressure & Pulse Height & Weight Complete

More information

Curriculum Vitae. 2005. MS. Nursing. California State University, Sacramento.

Curriculum Vitae. 2005. MS. Nursing. California State University, Sacramento. Curriculum Vitae, PhD, APRN-BC, PNP Professor, School of Nursing California State University Sacramento Email: dibaker@csus.edu EDUCATION 2009. Betty Irene Moore School of Nursing Postdoctoral Fellow.

More information

HIV and Hepatitis Co-infection. Martin Fisher Brighton and Sussex University Hospitals, UK

HIV and Hepatitis Co-infection. Martin Fisher Brighton and Sussex University Hospitals, UK HIV and Hepatitis Co-infection Martin Fisher Brighton and Sussex University Hospitals, UK Useful References British HIV Association 2010 http://www.bhiva.org/documents/guidelines/hepbc/2010/ hiv_781.pdf

More information

Pediatric Latent TB Diagnosis and Treatment

Pediatric Latent TB Diagnosis and Treatment Date Updated: April 2015 Guidelines Reviewed: 1. CDC Latent TB Guidelines 2. Harborview Pediatric Clinic Latent TB Management, 2010 3. Pediatric Associates Latent TB Guidelines, 2013 4. Seattle Children

More information

Surveillance for Hepatocellular Carcinoma

Surveillance for Hepatocellular Carcinoma Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April

More information

Hawaii Benchmarks Benefits under the Affordable Care Act (ACA)

Hawaii Benchmarks Benefits under the Affordable Care Act (ACA) Hawaii Benchmarks Benefits under the Affordable Care Act (ACA) 10/2012 Coverage for Newborn and Foster Children Coverage Outside the Provider Network Adult Routine Physical Exams Well-Baby and Well-Child

More information

IN-NETWORK MEMBER PAYS. Out-of-Pocket Maximum (Includes a combination of deductible, copayments and coinsurance for health and pharmacy services)

IN-NETWORK MEMBER PAYS. Out-of-Pocket Maximum (Includes a combination of deductible, copayments and coinsurance for health and pharmacy services) HMO-OA-CNT-30-45-500-500D-13 HMO Open Access Contract Year Plan Benefit Summary This is a brief summary of benefits. Refer to your Membership Agreement for complete details on benefits, conditions, limitations

More information

Rebecca Yates Coley, Ph.D.

Rebecca Yates Coley, Ph.D. Rebecca Yates Coley, Ph.D. Department of Biostatistics Johns Hopkins University Baltimore, MD January 5, 2016 rycoley@gmail.com www.rycoley.com github: rycoley Education Ph.D., Biostatistics, University

More information

CURRICULUM VITAE PERSONAL INFORMATION. Lindell A. Busciglio, M.D. 4729 North Habana Avenue Tampa, Florida 33614 (813) 251-8444

CURRICULUM VITAE PERSONAL INFORMATION. Lindell A. Busciglio, M.D. 4729 North Habana Avenue Tampa, Florida 33614 (813) 251-8444 CURRICULUM VITAE PERSONAL INFORMATION Name: Address: Lindell A. Busciglio, M.D. 4729 North Habana Avenue 33614 (813) 251-8444 4 Columbia Drive, Suite 820 33606 Research Address: 4200 North Armenia Avenue

More information

Preface. TTY: (888) 232-6348 or cdcinfo@cdc.gov. Hepatitis C Counseling and Testing, contact: 800-CDC-INFO (800-232-4636)

Preface. TTY: (888) 232-6348 or cdcinfo@cdc.gov. Hepatitis C Counseling and Testing, contact: 800-CDC-INFO (800-232-4636) Preface The purpose of this CDC Hepatitis C Counseling and Testing manual is to provide guidance for hepatitis C counseling and testing of individuals born during 1945 1965. The guide was used in draft

More information

Michael Leo Parchman, MD, MPH

Michael Leo Parchman, MD, MPH GENERAL INFORMATION Michael Leo Parchman, MD, MPH EDUCATION: Year Degree Discipline Institution/Location 2001 MPH University of Texas School of Public Health, Houston, TX 1982 MD Medicine University of

More information

CARE AND TREATMENT FOR PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV

CARE AND TREATMENT FOR PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV MINISTRY OF HEALTH PROCEDURE OF CARE AND TREATMENT FOR PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV HA NOI, 2007 1 TABLE OF CONTENTS Decision on the Issuance of the Procedure of Care and Treatment

More information

UCLA Asian Liver Program

UCLA Asian Liver Program CLA Program Update Program Faculty Myron J. Tong, PhD, MD Professor of Medicine Hepatology Director, Asian Liver Program Surgery Ronald W. Busuttil, MD, PhD Executive Chair Department of Surgery Director,

More information

ELIZABETH GAMMON, Ph.D., C.P.A. 2903 Conway St., Houston Texas 713.823.8952 elizabeth.a.gammon@uth.tmc.edu

ELIZABETH GAMMON, Ph.D., C.P.A. 2903 Conway St., Houston Texas 713.823.8952 elizabeth.a.gammon@uth.tmc.edu ELIZABETH GAMMON, Ph.D., C.P.A. 2903 Conway St., Houston Texas 713.823.8952 elizabeth.a.gammon@uth.tmc.edu EDUCATION University of Texas Health Science Center at Houston School of Public Health, Houston,

More information

AIDS In The Beginning Lessons for Public Health. Luther Terry Lecture

AIDS In The Beginning Lessons for Public Health. Luther Terry Lecture AIDS In The Beginning Lessons for Public Health James W. Curran, MD, MPH Rollins School of Public Health Emory University Luther Terry Lecture USPHS Scientific and Training Symposium May 18, 2015 What

More information

TRACKS INFECTIOUS DISEASE EPIDEMIOLOGY

TRACKS INFECTIOUS DISEASE EPIDEMIOLOGY Dr. Shruti Mehta, Director The development of antibiotics, improved access to safe food, clean water, sewage disposal and vaccines has led to dramatic progress in controlling infectious diseases. Despite

More information

Hepatitis C: Epidemiology, Transmission, and Screening. Jennifer Price, MD Assistant Professor of Medicine University of California San Francisco

Hepatitis C: Epidemiology, Transmission, and Screening. Jennifer Price, MD Assistant Professor of Medicine University of California San Francisco Activity Code FA376 Hepatitis C: Epidemiology, Transmission, and Screening Jennifer Price, MD Assistant Professor of Medicine University of California San Francisco Learning Objectives Upon completion

More information

EDUCATION AND TRAINING

EDUCATION AND TRAINING CURRICULUM VITAE NAME: CITIZENSHIP: BUSINESS ADDRESS: Tina Batra Hershey USA 130 DeSoto Street Crabtree Hall A744 Pittsburgh, PA 15261 Phone: 412-383-2229 Cell: 412-657-0714 E-mail: tbh16@pitt.edu EDUCATION

More information

Designing Clinical Addiction Research

Designing Clinical Addiction Research Designing Clinical Addiction Research Richard Saitz MD, MPH, FACP, FASAM Professor of Medicine & Epidemiology Boston University Schools of Medicine & Public Health Director, Clinical Addiction, Research

More information

Casey A. Knifsend Curriculum Vitae

Casey A. Knifsend Curriculum Vitae Casey A. Knifsend Curriculum Vitae Department of Psychology, Amador Hall 351C 6000 J Street Sacramento, CA 95819-6007 Phone: (916) 278-6191 Email: casey.knifsend@csus.edu EDUCATION Ph.D. in Developmental

More information

Chung-Bang Ben Weng, Ph.D, MSCS, MA

Chung-Bang Ben Weng, Ph.D, MSCS, MA Chung-Bang Ben Weng, Ph.D, MSCS, MA Assistant Professor Office of Physical Education National Taipei University 151, University RD San Shia District, New Taipei City, 23741 Taiwan 886-2-8674-1111 ext.

More information

Risk Factors for Alcoholism among Taiwanese Aborigines

Risk Factors for Alcoholism among Taiwanese Aborigines Risk Factors for Alcoholism among Taiwanese Aborigines Introduction Like most mental disorders, Alcoholism is a complex disease involving naturenurture interplay (1). The influence from the bio-psycho-social

More information

The University of Texas M. D. Anderson Cancer Center. Trainee Support Services 2002-2003 Annual Report. Caring Integrity Discovery

The University of Texas M. D. Anderson Cancer Center. Trainee Support Services 2002-2003 Annual Report. Caring Integrity Discovery The University of Texas M. D. Anderson Cancer Center Trainee Support Services 2002-2003 Annual Report Caring Integrity Discovery Table of Contents Section 1: Summary of Trainee Metrics for 2002-2003 and

More information

Wen-Tai Hsu. School of Economics Office: +65-6808 5455. 90 Stamford Road wentai@umn.edu

Wen-Tai Hsu. School of Economics Office: +65-6808 5455. 90 Stamford Road wentai@umn.edu Curriculum Vitae Personal Data/Contact Information Office Address Wen-Tai Hsu June 2015 Telephone Number, Email, etc School of Economics Office: +65-6808 5455 Singapore Management University E-mail: wentaihsu@smu.edu.sg

More information

HIV/AIDS Prevention and Care

HIV/AIDS Prevention and Care HIV/AIDS Prevention and Care Nancy S. Padian, PhD, MPH Professor, Obstetrics, Gynecology & Reproductive Sciences Associate Director for Research, Global Health Sciences and AIDS Research Institute: University

More information

Yale New Haven Health System Center for Healthcare Solutions

Yale New Haven Health System Center for Healthcare Solutions Table of Contents Education and Training Yale New Haven Health System Center for Healthcare Solutions 2009-2010 Fall/Winter Course Guide TOPICS center@ynhh.org www.yalenewhavenhealth.org/healthcaresolutions

More information